Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy.
about
Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national surveyReview article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel diseaseChinese herbal medicines in the treatment of IBD and colorectal cancer: a review.Etiology, diagnosis, and therapeutic management of granuloma annulare: an update.Disseminated granuloma annulare: a cutaneous adverse effect of anti-tnf agentsIdentification of Novel Single Chain Fragment Variable Antibodies Against TNF-α Using Phage Display TechnologyRisks and benefits of biologic therapy for inflammatory bowel diseases.Psoriatic arthritis treatment: biological response modifiersCutaneous adverse events of biological therapy for psoriasis: review of the literature.The logics of leukocytapheresis as a natural biological therapy for inflammatory bowel disease.Lessons for lupus from tumour necrosis factor blockade.Perforating folliculitis associated with tumour necrosis factor-alpha inhibitors administered for rheumatoid arthritis.Paradoxical adverse effects of anti-TNF-alpha treatment: onset or exacerbation of cutaneous disorders.A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease.Immune-mediated inflammatory reactions and tumors as skin side effects of inflammatory bowel disease therapy.Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders.Case Report of Lichen Planopilaris Occurring in a Pediatric Patient Receiving a Tumor Necrosis Factor α Inhibitor and a Review of the Literature.Immunology of cutaneous vasculitis associated with both etanercept and infliximab.Biologics in dermatology: adverse effects.Production and Purification of a Novel Anti-TNF-α Single Chain Fragment Variable AntibodyPositions of selective leukocytapheresis in the medical therapy of ulcerative colitis.Psoriasiform eruption induced by infliximab.Alopecia areata following adalimumab.Cutaneous vasculitis associated with infliximab in the treatment of rheumatoid arthritis.Generalized erythroderma and palmoplantar hyperkeratosis in a patient receiving TNF-alpha antagonist therapy.
P2860
Q24816756-45757F9C-3192-4AB1-AEBD-7C024C365EFEQ26822029-AA58F249-B455-455F-9026-6271133ACE7BQ34100569-02867203-0582-414D-8807-26DF872CEC7BQ34733315-CD6B9216-8121-49EC-A926-83B58996DBB8Q35749087-A4D49210-F2B8-4627-9A54-E801F5B15BAFQ35899838-3F04D375-8497-48B9-82B1-0F7DE4447619Q35929544-85215B32-F6B4-4BCA-8EBE-9CF1BE41893AQ36040084-CB805C93-F205-4D2D-BB8A-CC0C584B2326Q36276703-607AA7D0-D048-4489-81CE-C79667947DA2Q36446929-DCF54E4A-DBB6-43B1-ADBC-354CAE0701EEQ36677012-A0372B2E-DC9F-4272-B42D-C50F42BC9448Q36708366-D0D912F4-6AF2-4D26-9113-6612746ACCF7Q37754686-9A801F07-7DDB-4618-8C6A-3BB7370D8765Q37814549-7B32F064-09EE-4B5D-ADCC-122352506CE6Q38179468-8736E3F3-CA4A-4FE1-A17A-4A233ED7EB4BQ38632657-99E50438-AE01-485E-A66B-CF8958D1591BQ38721553-87F1E82F-3E3F-4F50-A564-75C15594DF90Q40430557-BD3E70BD-8186-4AFC-A7EF-F0798B0CAE55Q41120913-AF303F5F-001D-4BFC-AD32-F02BAF58DF6EQ41858564-1607EF2B-5502-4228-85A2-11B1DAFC3946Q42726307-4CD81C9A-458D-42DF-9BC9-085F1030D825Q44741635-72A0141B-E6AE-44A2-86BA-FB1A31735DBFQ45053630-DF6D799F-B65F-4098-9AF0-F4BFD9C1D628Q46737707-B73941BD-4603-48BC-9EFF-4FF826822A98Q50871295-07A7ECD0-EA3A-47A6-9354-6467BA24495F
P2860
Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy.
@en
Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy.
@nl
type
label
Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy.
@en
Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy.
@nl
prefLabel
Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy.
@en
Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy.
@nl
P2093
P921
P356
P1433
P1476
Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy.
@en
P2093
J M Naeyaert
N Van Den Bossche
P304
P356
10.1159/000069965
P577
2003-01-01T00:00:00Z